Kendle has acquired DecisionLine Clinical Research Corp., a privately held, early phase CRO with a state-of-the-art medical facility in Toronto, Canada. DecisionLine specializes in Phase I studies involving the measurement of pharmacodynamic effects of central nervous system (CNS) drugs. The company adds scientific expertise with psychopharmacology exploratory/translational medicine capabilities as well as drug development consulting, medical writing, data management, biostatistics and other sup...